BiomX Inc

ASE:PHGE   3:59:46 PM EDT
6.35
+0.11 (+1.76%)
: $6.45 +0.10 (+1.58%)
Other Pre-Announcement

Biomx Reports Third Quarter 2020 Financial Results And Announces Expanded Portfolio Of Phage Therapy Candidates

Published: 11/12/2020 11:45 GMT
BiomX Inc. (PHGE) - Biomx Reports Third Quarter 2020 Financial Results and Announces Expanded Portfolio of Phage Therapy Candidates.
Biomx Inc - Announces Expanded Portfolio of Phage Therapy Candidates.
Biomx Inc - Expects to Initiate a Phase 2 Cosmetic Clinical Study of Phage Therapy Bx001 in Q1 of 2021.
Biomx Inc - Results Expected in Q2 of 2021 From Phase 2 Cosmetic Clinical Study of Phage Therapy Bx001.
Biomx Inc - Cash, Equivalents, Short-term Deposits Are Expected to Be Sufficient to Fund Current Operating Plan Through Mid-2022.